252 related articles for article (PubMed ID: 16390030)
1. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].
Tsolaki M; Trontzos C; Kazis A
Hell J Nucl Med; 2005; 8(3):187-90. PubMed ID: 16390030
[TBL] [Abstract][Full Text] [Related]
2. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
[TBL] [Abstract][Full Text] [Related]
3. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
Kudo Y
Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
[TBL] [Abstract][Full Text] [Related]
4. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
Huddleston DE; Small SA
Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
[TBL] [Abstract][Full Text] [Related]
5. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.
Tu P; Fu H; Cui M
Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease.
Cui M; Ono M; Kimura H; Kawashima H; Liu BL; Saji H
Nucl Med Biol; 2011 Apr; 38(3):313-20. PubMed ID: 21492779
[TBL] [Abstract][Full Text] [Related]
7. [Amyloid-plaque imaging of the brain using PET].
Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
[TBL] [Abstract][Full Text] [Related]
8. Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization.
Shoghi-Jadid K; Barrio JR; Kepe V; Wu HM; Small GW; Phelps ME; Huang SC
Nucl Med Biol; 2005 May; 32(4):337-51. PubMed ID: 15878503
[TBL] [Abstract][Full Text] [Related]
9. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
[TBL] [Abstract][Full Text] [Related]
10. Current status of PET-imaging probes of β-amyloid plaques.
Koo J; Byun Y
Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
[TBL] [Abstract][Full Text] [Related]
11. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease.
Yang Y; Cui M
Eur J Med Chem; 2014 Nov; 87():703-21. PubMed ID: 25305715
[TBL] [Abstract][Full Text] [Related]
13. Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?
Dubroff JG; Nasrallah IM
Acad Radiol; 2015 Aug; 22(8):988-94. PubMed ID: 26100192
[TBL] [Abstract][Full Text] [Related]
14. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease.
Ono M; Saji H
J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky DM; Zhang B; Gur TL; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2002; 19(1-2):7-10. PubMed ID: 12212796
[TBL] [Abstract][Full Text] [Related]
16. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled Chalcone Derivatives as Potential Radiotracers for β-Amyloid Plaques Imaging.
Capponi PC; Mari M; Ferrari E; Asti M
Molecules; 2023 Apr; 28(7):. PubMed ID: 37049995
[TBL] [Abstract][Full Text] [Related]
18. Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.
Technol Eval Cent Assess Program Exec Summ; 2013 Feb; 27(5):1-4. PubMed ID: 23589929
[No Abstract] [Full Text] [Related]
19. Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.
Noda-Saita K; Yoneyama A; Shitaka Y; Hirai Y; Terai K; Wu J; Takeda T; Hyodo K; Osakabe N; Yamaguchi T; Okada M
Neuroscience; 2006; 138(4):1205-13. PubMed ID: 16460878
[TBL] [Abstract][Full Text] [Related]
20. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.
Ono M
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
